An Open-Label Pilot Trial To Collect And Evaluate Data On The Use Of Migranal [dihydroergotamine mesilate] In The Treatment Of Two Acute Migraine Attacks Associated With Cutaneous Allodynia

Trial Profile

An Open-Label Pilot Trial To Collect And Evaluate Data On The Use Of Migranal [dihydroergotamine mesilate] In The Treatment Of Two Acute Migraine Attacks Associated With Cutaneous Allodynia

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2011

At a glance

  • Drugs Dihydroergotamine mesilate (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2011 Actual end date Aug 2009 added as reported by ClinicalTrials.gov.
    • 13 Oct 2011 Actual initiation date Aug 2006 added as reported by ClinicalTrials.gov.
    • 13 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top